Phase I/II Study of Stereotactic Radiosurgery with Concurrent Administration of Olaparib Followed by Adjuvant Combination of Durvalumab and Physician’s Choice Systemic Therapy in Subjects with Breast Cancer Brain Metastases

Status: Open to Accrual

Learn more:

• clinicaltrials.gov: #NCT04711824

Study Contact: studies@hoosiercancer.org; (317) 921-2050.